Palla Pharma logo

PAL - Palla Pharma News Story

A$0.46 -0.0  -1.1%

Last Trade - 1:43am

Sector
Healthcare
Size
Micro Cap
Market Cap £40.0m
Enterprise Value £50.1m
Revenue £12.4m
Position in Universe 1008th / 1898

BRIEF-Palla Pharma Posts FY Revenue From Ordinary Activities $23.7 Mln Vs $54.8 Mln

Fri 26th February, 2021 1:24am
Feb 26 (Reuters) - Palla Pharma Ltd  PAL.AX :
    * FY REVENUE FROM ORDINARY ACTIVITIES $23.7 MILLION VERSUS
$54.8
MILLION
    * FY NET LOSS ATTRIBUTABLE $34.8 MILLION VERSUS LOSS $7.6
MILLION

Source text for Eikon:  ID:nASX4brF5Q 
Further company coverage:  PAL.AX 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.